Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC, explain how Mayo Clinic Laboratories' gene panel establishes a diagnosis of Lynch syndrome, which heightens the risk for several cancers. Test results can guide cancer surveillance for patients and their families.

(00:32)
 Would each of you share a little bit about yourselves and your background? Dr. Shen?

(01:25)
 Rihanna, could we have you give a little background about yourself as well?

(01:48)
 Could you provide us with an overview of Lynch syndrome?

(03:44)
 Can you expand on why genetic testing for Lynch syndrome is so important?

(06:03)
 Who would benefit from Lynch testing?

(07:51)
 Is Lynch syndrome the only type of inherited predisposition to colon cancer?

(08:48)
 Does the healthcare provider order these tests, and what kind of samples should be considered in these patients?

(10:50)
 Are there any limitations to the types of variants that can be detected by this test? And how does Mayo Clinic Laboratories ensure comprehensive results for patients?

(14:24)
 How are the results used in patient care?

(16:33)
 Could you summarize the benefits of these tests and of doing them at Mayo Clinic Laboratories?